Choosing Wisely: The American Society for Radiation Oncology's Top 5 list

Practical Radiation Oncology

Volumn 4, Issue 6, 2014, Pages 349-355

  Hahn, Carol ^a   Kavanagh, Brian ^b   Bhatnagar, Ajay ^c   Jacobson, Geraldine ^d   Lutz, Stephen ^e   Patton, Caroline ^f   Potters, Louis ^g   Steinberg, Michael ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c 21ST CENTURY ONCOLOGY   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e Blanchard Valley Regional Cancer Center   (United States)

^f American Society for Radiation Oncology   (United States)

^g Northwell Health   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONSERVATIVE TREATMENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL SOCIETY; ONCOLOGY; PRACTICE GUIDELINE; PROSTATE CANCER; PROTON THERAPY; REGISTER; TUMOR INVASION; WHOLE BREAST RADIOTHERAPY; BONE NEOPLASMS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; MALE; PATIENT PARTICIPATION; PROCEDURES; PROSTATIC NEOPLASMS; SECONDARY; STANDARDS;

BONE NEOPLASMS; BREAST NEOPLASMS; CHOICE BEHAVIOR; FEMALE; HUMANS; MALE; PATIENT PARTICIPATION; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY;

EID: 84912136805     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.06.003     Document Type: Article

References (33)

1. Elkin E.B., Bach P.B. Cancer's next frontier: Addressing high and increasing costs. JAMA 2010, 303:1086-1087.
2. Brody H. Medicine's ethical responsibility for health care reform-the Top Five list. N Engl J Med 2010, 362:283-285.
3. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
4. Veronesi U., Luini A., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 328:1587-1591.
5. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 366:2087-2106.
6. Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716.
7. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345:1378-1387.
8. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
9. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 2008, 9:331-341.
10. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 2008, 371:1098-1107.
11. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
12. Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 81:59-68.
13. Thompson I.M., Klotz L. Active surveillance for prostate cancer. JAMA 2010, 304:2411-2412.
14. Bastian P.J., Carter B.H., Bjartell A., et al. Insignificant prostate cancer and active surveillance: From definition to clinical implications. Eur Urol 2009, 55:1321-1330.
15. Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010, 28:126-131.
16. Lutz S., Berk L., Chang E., et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 79:965-976.
17. Chow E., Harris K., Fan G., Tsao M., Sze W.M. Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 2007, 25:1423-1436.
18. Fairchild A., Barnes E., Ghosh S., et al. International patterns of practice in palliative radiotherapy for painful bone metastases: Evidence-based practice?. Int J Radiat Oncol Biol Phys 2009, 75:1501-1510.
19. Chow E., van der Linden Y.M., Roos D., et al. Single versus multiple fractions of repeat radiation for painful bone metastases: A randomised, controlled, non-inferiority trial. Lancet Oncol 2013, 15:164-171.
20. Howell D.D., James J.L., Hartsell W.F., et al. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: A subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer 2013, 119:888-896.
21. van der Linden Y.M., Steenland E., van Houwelingen H.C., et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 2006, 78:245-253.
22. Andreo P. On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams. Phys Med Biol 2009, 54:N205-N215.
23. Paganetti H. Range uncertainties in proton therapy and the role of Monte Carlo simulations. Phys Med Biol 2012, 57:R99-R117.
24. Sheets N.C., Goldin G.H., Meyer A.M., et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012, 307:1611-1620.
25. Yu J.B., Soulos P.R., Herrin J., et al. Proton versus intensity-modulated radiotherapy for prostate cancer: Patterns of care and early toxicity. J Natl Cancer Inst 2013, 105:25-32.
26. Coen J.J., Zietman A.L., Rossi C.J., et al. Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: A case-matched analysis. Int J Radiat Oncol Biol Phys 2012, 82:e25-e31.
27. Steinberg M.L., Konski A. Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States. Cancer J 2009, 15:333-338.
28. Barnett G.C., Wilkinson J.S., Moody A.M., et al. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 2012, 82:715-723.
29. Mukesh M.B., Barnett G.C., Wilkinson J.S., et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 2013, 31:4488-4495.
30. Kavanagh B.D., Rabinovitch R., Mohideen N. Improved cosmesis in early breast cancer using conformal radiotherapy. J Clin Oncol 2013, 31:4483-4484.
31. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82:254-264.
32. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-2092.
33. Smith B.D., Pan I.W., Shih Y.C., et al. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 2011, 103:798-809.